Vojtesek B - Search Results

1

Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.

Mad'arová J, Lukesová M, Hlobilková A, Strnad M, Vojtesek B, Lenobel R, Hajdúch M, Murray PG, Perera S, Kolár Z. Mad'arová J, et al. Among authors: vojtesek b. Mol Pathol. 2002 Aug;55(4):227-34. doi: 10.1136/mp.55.4.227. Mol Pathol. 2002. PMID: 12147712 Free PMC article.

2

Expression of p53 protein in tissues and organs of human and mouse embryo.

Lichnovský V, Kamarád V, Kolár Z, Vojtĕsek B. Lichnovský V, et al. Among authors: vojtesek b. Acta Univ Palacki Olomuc Fac Med. 1994;138:25-7. Acta Univ Palacki Olomuc Fac Med. 1994. PMID: 8714088

3

Immunoreactivity of new antibodies anti-p53 and anti-MDM-2 in paraffin embedded tissue samples.

Andrejco M, Kaláb M, Oulton A, Kolár Z, Lichnovský V, Kod'ousek R, Vojtĕsek B. Andrejco M, et al. Among authors: vojtesek b. Acta Univ Palacki Olomuc Fac Med. 1996;140:63-7. Acta Univ Palacki Olomuc Fac Med. 1996. PMID: 9431695

4

Expression of p53 in glioblastoma multiforme cells: relationship to survival, proliferation and glycosylation.

Ehrmann J, Kolár Z, Kala M, Vojtĕsek B, Komenda S. Ehrmann J, et al. Among authors: vojtesek b. Cesk Patol. 1995 Aug;31(3):87-91. Cesk Patol. 1995. PMID: 9444787

5

Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.

Ehrmann J Jr, Kolár Z, Vojtĕsek B, Kala M, Komenda S, Oulton A. Ehrmann J Jr, et al. Among authors: vojtesek b. Neoplasma. 1997;44(5):299-304. Neoplasma. 1997. PMID: 9473789

6

Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos.

Lichnovský V, Kolár Z, Murray P, Hlobilková A, Cernochová D, Pospísilová E, Vojtĕsek B, Nenutil R. Lichnovský V, et al. Among authors: vojtesek b. Mol Pathol. 1998 Jun;51(3):131-7. doi: 10.1136/mp.51.3.131. Mol Pathol. 1998. PMID: 9850335 Free PMC article.

7

Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1.

Kolar Z, Flavell JR, Ehrmann J Jr, Rihakova P, Macak J, Lowe D, Crocker J, Vojtesek B, Young LS, Murray PG. Kolar Z, et al. Among authors: vojtesek b. J Pathol. 2000 Apr;190(5):604-12. doi: 10.1002/(SICI)1096-9896(200004)190:5<604::AID-PATH561>3.0.CO;2-P. J Pathol. 2000. PMID: 10727987

8

Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.

Kolár Z, Murray PG, Scott K, Harrison A, Vojtĕsek B, Dusek J. Kolár Z, et al. Among authors: vojtesek b. Mol Pathol. 2000 Feb;53(1):15-8. doi: 10.1136/mp.53.1.15. Mol Pathol. 2000. PMID: 10884916 Free PMC article.

9

Ehrmann J Jr, Galuszková D, Ehrmann J, Krc I, Jezdinská V, Vojtések B, Murray PG, Koláo Z. Ehrmann J Jr, et al. Among authors: vojtesek b. Pathol Oncol Res. 2000;6(2):130-5. doi: 10.1007/BF03032363. Pathol Oncol Res. 2000. PMID: 10936789 Free article.

10

Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases.

Kotala V, Uldrijan S, Horky M, Trbusek M, Strnad M, Vojtesek B. Kotala V, et al. Among authors: vojtesek b. Cell Mol Life Sci. 2001 Aug;58(9):1333-9. doi: 10.1007/PL00000944. Cell Mol Life Sci. 2001. PMID: 11577989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters